Hepatocellular Carcinoma
📧 Sign up to get email alerts when something new happens for Hepatocellular Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-06-08Clinical Trial Update: Phase I/II Study of OPB-31121 in Patients With Progressive Hepatocellular Carcinoma [Phase 1, Phase 2]
Clinical trial update reporting results from a Phase 1/2 study of OPB-31121 in progressive hepatocellular carcinoma.
-
CLINICAL_TRIALS trial_result · 2015-06-03Clinical Trial Update: Cancer Stem Cells Vaccine Therapy in Treating Hepatocellular Cancer Patients [Phase 1, Phase 2]
A phase 1/2 clinical trial evaluating Cancer Stem Cells Vaccine Therapy for hepatocellular carcinoma has completed enrollment. The update pr…
-
CLINICAL_TRIALS trial_result · 2015-05-28Clinical Trial Update: Efficacy of Sofosbuvir With Ribavirin Administered Pre-Transplant in Preventing Hepatitis C Virus (HCV) Recurrence Post-Transplant [Phase 2]
Phase 2 trial evaluating whether pre-transplant sofosbuvir with ribavirin reduces hepatitis C recurrence after liver transplantation. The st…
-
CLINICAL_TRIALS trial_result · 2015-05-27Clinical Trial Update: Axitinib For The Treatment Of Advanced Hepatocellular Carcinoma [Phase 2]
Phase 2 trial update of axitinib for advanced hepatocellular carcinoma has completed with results posted in 2015.
-
CLINICAL_TRIALS research · 2015-05-25Clinical Trial Update: HR Combined With FOLFOX4 for HCC With PVTT [Phase 2]
Phase 2 clinical trial evaluating HR in combination with the FOLFOX4 regimen for hepatocellular carcinoma with portal vein tumor thrombus; s…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-05-22Clinical Trial Update: Combination SBRT With TACE for Unresectable Hepatocellular Carcinoma [Phase 1, Phase 2]
A Phase 1/2 trial evaluating the combination of stereotactic body radiotherapy (SBRT) and transarterial chemoembolization (TACE) for unresec…
-
CLINICAL_TRIALS trial_result · 2015-05-20Clinical Trial Update: Drug-eluting Bead in Hepatocellular Carcinoma [Phase 4]
Phase 4 clinical trial of a drug-eluting bead for hepatocellular carcinoma conducted by Seoul National University Hospital has completed.
-
CLINICAL_TRIALS research · 2015-05-19Clinical Trial Update: MiRNA as a Diagnostic and Prognostic Biomarker of Hepatocellular Carcinoma
This clinical trial update discusses a study evaluating microRNA as a diagnostic and prognostic biomarker for hepatocellular carcinoma.
-
CLINICAL_TRIALS trial_result · 2015-05-18Clinical Trial Update: A Study of Changes in Hepatic Function During Radiation Therapy Using Hepatobiliary Single Photon Emission Tomography (SPECT)
A completed clinical trial evaluating changes in hepatic function during radiation therapy using hepatobiliary SPECT imaging in hepatocellul…
-
CLINICAL_TRIALS trial_result · 2015-05-15Clinical Trial Update: Sorafenib Tosylate in Treating Younger Patients With Relapsed or Refractory Rhabdomyosarcoma, Wilms Tumor, Liver Cancer, or Thyroid Cancer [Phase 2]
This Phase 2 trial of sorafenib tosylate in children and young patients with relapsed or refractory rhabdomyosarcoma, Wilms tumor, hepatocel…
-
CLINICAL_TRIALS trial_result · 2015-05-13Clinical Trial Update: Use of TheraSphere® Yttrium-90 Glass Microspheres for Primary and Metastatic Liver Tumors [Phase 1, Phase 2]
This clinical trial update describes the use of TheraSphere Yttrium-90 glass microspheres for primary hepatocellular carcinoma and liver met…
-
CLINICAL_TRIALS trial_result · 2015-04-29Clinical Trial Update: Lapatinib Ditosylate in Treating Patients With Unresectable Liver or Biliary Tract Cancer [Phase 2]
Phase 2 trial evaluating lapatinib ditosylate in adults with unresectable liver and biliary tract cancers; results from the study have been …
-
CLINICAL_TRIALS trial_result · 2015-04-29Clinical Trial Update: Profile of Soluble and Cellular Biomarkers and of Functional Imaging During Antiangiogenic Therapies in Cancer Patients
A terminated clinical trial update studying soluble and cellular biomarkers and functional imaging during antiangiogenic therapies in cancer…
-
CLINICAL_TRIALS research · 2015-04-27Clinical Trial Update: RFA Combined With Oxaliplatin + 5-FluoroUracil/LeucoVorin (5-FU/LV) (FOLFOX4) for Recurrent HCC [Phase 2]
Phase 2 clinical trial exploring the combination of radiofrequency ablation with oxaliplatin and 5-FU/leucovorin (FOLFOX4) for recurrent hep…
-
CLINICAL_TRIALS research · 2015-04-23Clinical Trial Update: Evaluation of Proteasome as a Marker of Hepatocellular Carcinoma in Cirrhotic Patients Following Curative Treatment [NA]
Clinical trial update evaluating whether proteasome serves as a biomarker for hepatocellular carcinoma in cirrhotic patients after curative …
-
CLINICAL_TRIALS trial_result · 2015-04-21Clinical Trial Update: Phlebotomy and Risk of Hepatocellular Carcinoma in Patients With Compensated Alcoholic Cirrhosis [Phase 3]
Phase 3 trial evaluating phlebotomy to reduce hepatocellular carcinoma risk in patients with compensated alcoholic cirrhosis and iron overlo…
-
CLINICAL_TRIALS trial_result · 2015-04-17Clinical Trial Update: Trans-catheter Chemo-embolization Combined With rAd-p53 Gene Injection in Treatment of Advanced Hepatocellular Carcinoma [Phase 2]
Phase 2 trial evaluating trans-catheter chemoembolization combined with rAd-p53 gene therapy for advanced hepatocellular carcinoma.
-
CLINICAL_TRIALS trial_result · 2015-04-16Clinical Trial Update: Safety Study of Cord Blood-derived Cytokine-induced Killer Cells in Patients With Solid Tumor After Radical Resection [Phase 1]
Phase 1 safety study of cord blood–derived cytokine-induced killer (CIK) cells in patients with solid tumors after radical resection. The li…
-
CLINICAL_TRIALS withdrawal · 2015-04-16Clinical Trial Update: AZD6244 and Sorafenib in Advanced Hepatocellular Carcinoma [Phase 1, Phase 2]
Clinical trial evaluating AZD6244 (selumetinib) and sorafenib in advanced hepatocellular carcinoma was terminated (Phase 1/Phase 2) accordin…
-
CLINICAL_TRIALS withdrawal · 2015-04-16Clinical Trial Update: A Phase Ib Study of Stereotactic Body Radiotherapy (SBRT) Plus Sorafenib in Patients With Unresectable Hepatocellular Carcinoma (HCC) [Phase 1]
Phase Ib trial of stereotactic body radiotherapy plus sorafenib for unresectable hepatocellular carcinoma has been withdrawn. The study stat…
-
CLINICAL_TRIALS trial_result · 2015-04-15Clinical Trial Update: Thalidomide and Chemoembolization With Doxorubicin in Treating Patients With Liver Cancer That Cannot be Removed by Surgery [Phase 2]
Phase 2 trial evaluating thalidomide in combination with doxorubicin chemoembolization for unresectable hepatocellular carcinoma; the study …
-
CLINICAL_TRIALS research · 2015-04-14Clinical Trial Update: OBT Measurement to Differentiate Between Presence and Absence of HCC Determined by MRI
The trial update describes a study evaluating whether OBT measurements on MRI can differentiate the presence versus absence of hepatocellula…
-
CLINICAL_TRIALS trial_result · 2015-04-13Clinical Trial Update: A Safety and Efficacy Study of DENSPM in Patients With Liver Cancer Who Are Not Eligible for Surgical Care [Phase 1, Phase 2]
The DENSPM trial in hepatocellular carcinoma patients not eligible for surgical care (Phase 1/2) was terminated.
-
CLINICAL_TRIALS trial_result · 2015-04-03Clinical Trial Update: Safety Study of BAY73-4506 in Patients With Hepatocellular Carcinoma [Phase 2]
A Phase 2 safety study of BAY73-4506 in patients with hepatocellular carcinoma has completed.
-
FDA label_change · 2015-03-27FDA Approved: EOVIST — Supplemental Application (Bayer HealthCare Pharmaceuticals Inc.)
FDA notes Bayer's supplemental application for EOVIST (gadoxetate disodium) to modify the drug's labeling.